KẾT QUẢ PHẪU THUẬT NỘI SOI QUA ĐƯỜNG MIỆNG ĐIỀU TRỊ UNG THƯ TUYẾN GIÁP Ở TRẺ EM

Abstract

Objects: Our study aims to evaluate the treatment results of pediatric patients (≤18) with thyroid cancer who were treated by TOETVA in Ha Noi Medical University Hospital. Subjects and methods: A prospective study was performed on 8 eligible patients who underwent TOETVA due to thyroid cancer in Department of Oncology and Palliative Care from 02/2020 to 06/2022. Results: This study included 8 patients, in which female accounted for 87.5%. No case had a personal or family history of thyroid cancer. The mean age was 16± 2.6 (11-18 years old), thyroid lobectomy + ipsilateral CND was applied in 7 cases (87.5%), total thyroidectomy + bilateral CND: 1 case (12.5%). There were no cases of conversion to open surgery. Meantime operation was 92.1± 21.2 and 120± 0.1 minutes, respectively. The average postoperative period was 5.63±1.5 days (3-7 days). The mean number of retrieved central nodes was 7.13±3.2, in which there were 5 cases with lymph node metastasis (62.5%). There were 1 case (12.5%) showing transient vocal cord palsy. However, there was no case of transient hypoparathyroidism, permanent vocal cord palsy, and numb chin. Conclusion: TOETVA is a safe method for children with low complication rates.